Security key
59102M104
- Type / Class
- Equity / COM
- Total 13F shares
- 6,764,212
- Share change
- +1,372,995
- Total reported value
- $10,956,656
- Price per share
- $1.62
- Number of holders
- 54
- Value change
- +$2,099,977
- Number of buys
- 24
- Number of sells
- 25
Report period
Q4 2025
Institutions
54
Top holders
10
MGX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Metagenomi Therapeutics, Inc. SEC filings
Metagenomi Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59102M104
Recent filing periods:
Ownership snapshot
Top shareholders of MGX - Metagenomi Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BAYER HEALTHCARE LLC
13D/G signal
—
Evidence rows
50
Latest as of
05 Dec 2025
3/4/5
13F
Highest disclosed value: $11,666,871
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAYER HEALTHCARE LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$11,666,871
4,050,997 shares
|
— | 13 Feb 2024 |
| Novo Holdings A/S |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$5,008,824
1,739,175 shares
|
— | 09 Feb 2024 |
| Sebastian Bernales |
3/4/5
Director
|
—
mixed-class rows
|
$6,620,950
3,147,422 shares
mixed-class rows
|
— | 01 Apr 2024 |
| Brian C. Thomas |
3/4/5
Director
|
—
mixed-class rows
|
$4,449,170
2,706,960 shares
mixed-class rows
|
-$30,549 | 05 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$2,942,378
1,241,510 shares
|
— | 30 Sep 2025 |
| Sozo Ventures GP II, L.P. |
13F
Company
|
—
class O/S missing
|
$1,331,404
581,577 shares
|
— | 30 Sep 2025 |
| Catalio Capital Management, LP |
13F
Company
|
—
class O/S missing
|
$1,253,713
528,993 shares
|
— | 30 Sep 2025 |
| Peapod Lane Capital LLC |
13F
Company
|
—
class O/S missing
|
$1,218,421
513,815 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
54
Shares
6,764,212
Rows loaded
54
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
57
Q4 2025 holders
54
Holder diff
-3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend